The Lancet Summit
2nd biennial cancer control in China

We are pleased to announce The Lancet Summit: 2nd biennial cancer control in China, a multi-track cancer control conference taking place in Shanghai, China, in 2027.

The Lancet Summit: 2nd biennial cancer control in China will build on previous successful Summits and conferences on cancer control in Asia hosted by The Lancet, The Lancet Oncology, and other Lancet journals. This edition will be a collaboration between several Lancet journals (including The Lancet Haematology, The Lancet Obstetrics, Gynaecology & Women's Health, The Lancet Medical Imaging & Theranostics, and The Lancet) who have convened and collaborated with a renowned Advisory Board to produce a comprehensive programme and a stellar faculty of speakers.

Over 3 days from Mar 19-21, 2027, our esteemed faculty will tackle the challenges posed by common cancers through the opportunities provided by new technologies, including imaging and AI, in China through a lens of cancer control. We have curated a contemporary programme consisting of three parallel tracks covering haematological cancers, women's cancers, and cancer imaging. The meeting will also feature cross-cutting plenary sessions, of interest to all attendees, and a unique half-day symposium dedicated to AI in cancer research. Finally, we will showcase some of the latest research from across China and beyond in dedicated oral abstract sessions and via poster presentations.

Of interest to all in the field of oncology, including physicians, nurses, pathologists, radiologists, oncologists, surgeons, palliative care specialists, epidemiologists, public health practitioners, researchers, and policy makers, The Lancet Summit offers you a unique opportunity to connect with leading experts, engage with cutting-edge research, and help shape the future of cancer control.

We look forward to seeing you in Shanghai in 2027!